These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36297609)

  • 21. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer's disease: evidence of potential intranasal brain targeting.
    Wen MM; Ismail NIK; Nasra MMA; El-Kamel AH
    Drug Deliv; 2021 Dec; 28(1):1188-1203. PubMed ID: 34121565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of droplet size on the stability, in vivo digestion, and oral bioavailability of vitamin E emulsions.
    Parthasarathi S; Muthukumar SP; Anandharamakrishnan C
    Food Funct; 2016 May; 7(5):2294-302. PubMed ID: 27101870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization.
    Shah BM; Misra M; Shishoo CJ; Padh H
    Drug Deliv; 2015; 22(7):918-30. PubMed ID: 24467601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
    Cherniakov I; Domb AJ; Hoffman A
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.
    El-Setouhy DA; Ibrahim AB; Amin MM; Khowessah OM; Elzanfaly ES
    Eur J Pharm Sci; 2016 Sep; 92():244-54. PubMed ID: 27154259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System.
    Jianxian C; Saleem K; Ijaz M; Ur-Rehman M; Murtaza G; Asim MH
    Int J Nanomedicine; 2020; 15():5217-5226. PubMed ID: 32801687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.
    Kawakami K; Yoshikawa T; Moroto Y; Kanaoka E; Takahashi K; Nishihara Y; Masuda K
    J Control Release; 2002 May; 81(1-2):65-74. PubMed ID: 11992679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-emulsifying drug delivery systems: a novel approach to deliver drugs.
    Salawi A
    Drug Deliv; 2022 Dec; 29(1):1811-1823. PubMed ID: 35666090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability.
    Nguyen TT; Duong VA; Maeng HJ
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
    Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
    Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.
    Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
    Drug Deliv Transl Res; 2018 Feb; 8(1):204-225. PubMed ID: 29204927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
    Jiang Y; Liu C; Zhai W; Zhuang N; Han T; Ding Z
    Int J Nanomedicine; 2019; 14():9217-9234. PubMed ID: 31819426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH; Patel RJ
    Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.
    Zhu Y; Ye J; Zhang Q
    Pharm Nanotechnol; 2020; 8(4):290-301. PubMed ID: 32781978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
    Sharma G; Mishra AK; Mishra P; Misra A
    AAPS PharmSciTech; 2009; 10(4):1321-30. PubMed ID: 19894122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies.
    Gadhave D; Tupe S; Tagalpallewar A; Gorain B; Choudhury H; Kokare C
    Int J Pharm; 2021 Sep; 607():121050. PubMed ID: 34454028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
    Gabr MM; Mortada SM; Sallam MA
    J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.